Bausch Health Companies Inc BHC
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover BHC, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
-
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
-
Bausch Health Companies to Present at Cowen Annual Health Care Conference
-
Toronto Stocks Climb, Loblaw Shares Rise on 4Q Profit, Revenue Growth
-
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
-
Salix Announces 2024 Gastrointestinal Health Scholars Program
-
Bausch Health Announces Board Refreshment
-
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
Trading Information
- Previous Close Price
- $9.20
- Day Range
- $9.16–9.39
- 52-Week Range
- $5.57–10.15
- Bid/Ask
- $9.32 / $9.74
- Market Cap
- $3.43 Bil
- Volume/Avg
- 1.2 Mil / 2.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 2.68
- Price/Sales
- 0.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 20,270
- Website
- https://www.bauschhealth.com
Comparables
Valuation
Metric
|
BHC
|
BLCO
|
ASRT
|
---|---|---|---|
Price/Earnings (Normalized) | 2.68 | 20.37 | 1.73 |
Price/Book Value | — | 0.83 | 0.71 |
Price/Sales | 0.39 | 1.34 | 0.49 |
Price/Cash Flow | 2.12 | 20.57 | 1.49 |
Price/Earnings
BHC
BLCO
ASRT
Financial Strength
Metric
|
BHC
|
BLCO
|
ASRT
|
---|---|---|---|
Quick Ratio | 0.68 | 0.74 | 1.30 |
Current Ratio | 1.30 | 1.74 | 1.83 |
Interest Coverage | 0.69 | 0.36 | −85.86 |
Quick Ratio
BHC
BLCO
ASRT
Profitability
Metric
|
BHC
|
BLCO
|
ASRT
|
---|---|---|---|
Return on Assets (Normalized) | 4.86% | 2.15% | −87.36% |
Return on Equity (Normalized) | — | 3.72% | −156.35% |
Return on Invested Capital (Normalized) | 10.43% | 4.42% | −128.46% |
Return on Assets
BHC
BLCO
ASRT
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Cjvxz | $78.2 Bil | |
MKKGY
| Merck KGaA ADR | Wdcyvlt | $74.0 Bil | |
HLN
| Haleon PLC ADR | Txm | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yyzxt | $15.0 Bil | |
VTRS
| Viatris Inc | Vqvw | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ydjr | $12.7 Bil | |
CTLT
| Catalent Inc | Csfstg | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bdqm | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Yrqj | $3.8 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qdpzxb | $3.7 Bil |